Overview

This trial is active, not recruiting.

Conditions fatigue, musculoskeletal diseases
Treatments compensatory workplace exercise (cwe) - comparative group, individual resistance exercise (ire) - intervention group
Sponsor Rosimeire Simprini Padula
Start date October 2015
End date December 2016
Trial size 352 participants
Trial identifier NCT02172053, 454.709

Summary

Studies show that exercise resistance in workplace can reduce the symptoms of induced labor, however, the effectiveness of such programs depends on the characteristics of the training fatigue. Thus, it is expected that this study the intervention group with training heavy using progressive resistance exercise protocol will be better in reducing fatigue when compare with light training group.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking double blind (investigator, outcomes assessor)
Primary purpose prevention
Arm
(Active Comparator)
Comparative Group will receive a light training protocol including warming up, stretching and resisted exercise using elastic bands.
compensatory workplace exercise (cwe) - comparative group
The comparative group will receive warming up and stretching and light resisted exercise with elastic bands. The exercise will realize three times per week, 20 minutes for day in total 60 minutes per week. With warming up for 5 minutes and 15 minutes of the specific training . The exercise will realize in 3 series with 10 repetitions and rest 30 seconds between series.
(Experimental)
Intervention group will receive training protocol including warming up, stretching a specific resistance training with increase progressive load.
individual resistance exercise (ire) - intervention group
Intervention group will receive warming up and stretching, and a specific resistance training with increase progress load. The exercise will realize three times per week, 20 minutes for day in total 60 minutes per week. With warming up and stretching for 5 minutes and 15 minutes of the specific training. The exercise will realize in 3 series with 10 repetitions and rest 30 seconds between series.

Primary Outcomes

Measure
Need for Recovery
time frame: up to 4 months
Fatigue
time frame: up to 4 months

Secondary Outcomes

Measure
Musculoskeletal symptoms
time frame: Outcome measures will be assessed at baseline and after 4 months.
Level of physical activity
time frame: Outcome measures will be assessed at baseline and after 4 months.
Perceived exposure
time frame: Outcome measures will be assessed at baseline and after 4 months.
Physical Fitness Assessment
time frame: Outcome measures will be assessed at baseline and after 4 months.
Productivity
time frame: Outcome measures will be assessed at baseline and after 4 months.

Eligibility Criteria

Male or female participants from 18 years up to 65 years old.

Inclusion Criteria: - sign informed consent Exclusion Criteria: - restriction by the medical department.

Additional Information

Official title Effectiveness of a Resistance Training Program in the Workplace to Muscle Fatigue Control in Industrial Workers: Cluster Randomized Controlled Trial.
Principal investigator Rosimeire S Padula
Description Background: This study is randomized clinical trial with double-blinded. The aim is evaluate the effectiveness the training heavy with resistance exercise program in the muscle fatigue control. Methods: This is a randomized controlled trial by cluster, in which workers who participate in the intervention group will perform resistance exercise protocols; and workers in the comparative group held only stretching exercises and light resistance training with elastic bands. Expected results: strong evidence that fatigue reducing after ten weeks in workers and improve in others outcomes. Not found in literature studies in occupational evaluating this aspect of training.
Trial information was received from ClinicalTrials.gov and was last updated in March 2016.
Information provided to ClinicalTrials.gov by Universidade Cidade de Sao Paulo.